Related Experiment Videos
Identification of anti-TNFalpha peptides with consensus sequence
1Department of Biochemistry, Beijing Institute of Basic Medical Sciences, P.O. Box 130(3), Beijing 100850, People's Republic of China.
Biochemical and Biophysical Research Communications
|October 16, 2003
Summary
Researchers identified novel peptides that bind to tumor necrosis factor alpha (TNFalpha). These peptides act as antagonists, inhibiting TNFalpha
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Tumor necrosis factor alpha (TNFalpha) is a key inflammatory cytokine.
- Dysregulation of TNFalpha is implicated in various autoimmune diseases.
- Developing targeted therapies for TNFalpha is a significant clinical need.
Purpose of the Study:
- To identify novel peptides that bind to TNFalpha using phage display.
- To characterize the TNFalpha-binding peptides as potential therapeutic agents.
- To evaluate the antagonistic activity of these peptides against TNFalpha.
Main Methods:
- Phage display biopanning was employed to select TNFalpha-binding peptides from a 12-mer library.
- Peptide binding specificity was confirmed through competitive elution assays.
- Selected peptides were expressed as GST-fused proteins and their inhibitory activity against TNFalpha was assessed in vitro.
Main Results:
- Several linear TNFalpha-binding peptides were identified, revealing a consensus binding motif.
- Phage-displayed peptides demonstrated specific binding to immobilized TNFalpha.
- Recombinant peptides effectively inhibited [125I]TNFalpha binding to TNFR1 and neutralized TNFalpha-induced cytotoxicity.
Conclusions:
- The identified peptides are potent antagonists of TNFalpha.
- The deduced consensus motif holds promise for developing low molecular weight anti-TNFalpha drugs.
- These findings suggest a new therapeutic strategy for TNFalpha-mediated inflammatory conditions.